Drug Profile
Research programme: progestogen-based therapeutics - Organon
Alternative Names: ORG 47241Latest Information Update: 20 Oct 2009
Price :
$50
*
At a glance
- Originator Organon
- Class Progesterone congeners
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Female genital diseases; Pregnancy
Most Recent Events
- 20 Oct 2009 Discontinued - Preclinical for Gynaecological disorders in USA (unspecified route)
- 20 Oct 2009 Discontinued - Preclinical for Pregnancy (Prevention) in USA (unspecified route)
- 07 Dec 2007 A compound from this programme has entered clinical development